相关实验视频
Updated: Aug 8, 2026

07:16
Thermal Ablation for the Treatment of Abdominal Tumors
Published on: March 7, 2011
34.6K
皮肤状甲状腺微癌的射频切除后续策略:定义对切除的反应系统
Xinyang Li1,2, Lin Yan2, Jing Xiao2
1School of Medicine, Nankai University, No.94 Weijin Road, Nankai District, 300071, Tianjin, China.
European radiology
|August 19, 2023
概括
一个新的响应移除系统有效地预测了在射频移除 (RFA) 后患有低风险乳头甲状腺小癌 (PTMC) 的患者的结果. 该系统将患者分为完整的,不确定的或不完整的响应组,指导个性化后续策略.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 医疗成像医学成像
背景情况:
- 乳头甲状腺微瘤 (PTMC) 是最常见的甲状腺癌类型.
- 射频除 (RFA) 是低风险PTMC的最小侵入性治疗选择.
- 预测临床结果和为PTMC患者量身定制后续治疗后RFA仍然是一个挑战.
研究的目的:
- 定义和验证一种响应-去除系统,用于预测RFA治疗的低风险PTMC患者的临床结果.
- 利用基于2015年美国甲状腺协会指南的动态风险分层.
- 为这些患者指导个性化后续策略.
主要方法:
- 对748名患有低风险PTMC且接受RFA (2014-2018) 的患者进行了回顾性审查.
- 根据1年的随访,分类为完整的,不确定的和不完整的响应组.
- 主要终点:局部瘤进展 (LTP) 和无病生存期 (DFS).
主要成果:
- 响应-消去系统显示出高预测准确度 (C指数:0.79).
- 长期治疗率有显著差异:1%在完全响应组,8.1%在不确定组,100%在不完全响应组.
- 在三个响应组中观察到DFS的显著差异 (p < 0.001).
结论:
- 定义的响应-去除系统有效地将PTMC患者RFA后分类为不同的临床结果队列.
- 这个系统为管理PTMC提供了一个新的范式,使得风险分层的后续行动成为可能.
- 该系统有助于定制持续的后续建议,以改善患者管理.
更多相关视频
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

